ESR1 and breast carcinoma: To be more specific, a significant microbial variation was observed across different breast cancer subtypes, including estrogen receptor-positive (ER-positive), progesterone receptor-positive (PR-positive), and human epidermal growth factor receptor 2-positive (HER2-positive), with specific bacterial taxa exhibiting a varying prevalence among these subtypes [11].